Published in Public Health Rep on June 30, 1988
Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160. J Clin Invest (1993) 0.87
Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection. PLoS One (2013) 0.84
Why clinical trials of AIDS vaccines are premature. Am J Public Health (1989) 0.81
New FDA drug approval policies and HIV vaccine development. Am J Public Health (1990) 0.80
Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery. Retrovirology (2017) 0.76
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (1988) 11.05
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A (1982) 7.81
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science (1986) 7.81
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (1985) 5.42
Variable and conserved neutralization antigens of human immunodeficiency virus. Nature (1987) 5.29
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci U S A (1985) 5.10
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science (1984) 3.20
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature (1986) 3.19
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci U S A (1987) 2.25
Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science (1985) 2.09
T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses. Nature (1986) 1.55
Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J Virol (1987) 1.47
Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes. Virology (1981) 1.43
Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am J Vet Res (1986) 1.22
Protection against feline leukemia by vaccination with a subunit vaccine. Infect Immun (1981) 1.16
Toward a vaccine against AIDS: rationale and current progress. Mt Sinai J Med (1986) 0.87
Unconventional vaccines: immunization with anti-idiotype antibody against viral diseases. Cancer Res (1985) 0.79
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (1988) 11.05
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A (1988) 8.40
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
Rapid cell culture assay technic for murine leukaemia viruses. Nature (1971) 5.87
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55
Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer (1970) 5.48
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (1985) 5.42
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A (1986) 4.68
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. Science (1981) 4.27
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses (1987) 3.67
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol (1990) 3.35
Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A (1980) 3.29
Quantitative infectivity assay for HIV-1 and-2. Nature (1988) 3.01
Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98
Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci U S A (1976) 2.86
Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol (1974) 2.84
Isolation of RD-114-like oncornavirus from a cat cell line. J Virol (1973) 2.61
Fractionation of DNA nucleotide transcripts from Moloney sarcoma virus and isolation of sarcoma virus-specific complementary DNA. J Virol (1976) 2.39
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28
Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A (1971) 2.26
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci U S A (1987) 2.25
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med (1991) 2.15
Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex. J Natl Cancer Inst (1969) 1.96
Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J Virol (1988) 1.95
Titration patterns of a murine sarcoma-leukemia virus complex: evidence for existence of competent sarcoma virions. Science (1968) 1.73
Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology (1976) 1.73
Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virus. J Virol (1977) 1.65
Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology (1972) 1.59
Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell (1977) 1.56
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol (1987) 1.49
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology (1978) 1.42
Isolation of human amnion cells transformed by rescuable murine sarcoma virus. Nat New Biol (1973) 1.41
A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A (1975) 1.37
Oncogenic and immunogenic potential of cloned HIX virus in mice and cats. Med Microbiol Immunol (1977) 1.37
Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus. J Virol (1971) 1.32
Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis. J Gen Virol (1971) 1.29
Molecular relatedness of mammalian RNA tumor viruses as determined by DNA hybridization. Science (1973) 1.28
Revertants of mouse cells transformed by murine sarcoma virus. 3. Metastable expression of virus functions in revertants retransformed by murine sarcoma virus. Virology (1974) 1.28
Elimination of the sarcoma genome from murine sarcoma virus transformed cat cells. Science (1976) 1.26
Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells. AIDS Res Hum Retroviruses (1987) 1.26
Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology (1972) 1.25
Characterization of integrated Moloney Sarcoma proviruses and flanking host sequences cloned in bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1980) 1.24
Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Virology (1976) 1.19
Reversion of murine sarcoma virus transformed mouse cells: variants without a rescuable sarcoma virus. Science (1972) 1.18
Productive infection and morphologic alteration of human cells by a modified sarcoma virus. J Natl Cancer Inst (1970) 1.17
Efficient release of murine xenotropic oncornavirus after murine leukemia virus infection of mouse cells. Virology (1975) 1.16
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1987) 1.14
Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks. Science (1978) 1.14
Radiation leukemia virus: quantitative tissue culture assay. Science (1969) 1.13
Viral infection across species barriers: reversible alteration of murine sarcoma virus for growth in cat cells. Science (1969) 1.13
Use of an established cat cell line for investigation and quantitation of feline oncornaviruses. J Natl Cancer Inst (1972) 1.13
Characterization of RNA from noninfectious virions produced by sarcoma positive-leukemia negative transformed 3T3 cells. Proc Natl Acad Sci U S A (1973) 1.11
Properties of mouse leukemia viruses. II. Isolation of viral components. Virology (1972) 1.10
Detection of some murine leukemia virus antigens in virus particles derived from 3T3 cells transformed only by murine sarcoma virus. Virology (1972) 1.06
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation. Arch Virol (1987) 1.05
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Cancer Res (1985) 1.01
Tissue culture assay of helper activity of murine leukemia virus for murine sarcoma virus. J Natl Cancer Inst (1968) 0.98
Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J Gen Virol (1988) 0.98
Identification of virus found in mouse lymphomas induced by HIX murine oncornavirus. J Virol (1978) 0.98
Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology (1979) 0.98
Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71. Virology (1981) 0.98
Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures. J Natl Cancer Inst (1969) 0.96
Role of carbohydrate in biological functions of Friend murine leukemia virus gp71. J Virol (1977) 0.94
Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF. J Virol (1988) 0.93
Replication of radiation-induced murine leukemia virus in normal and transformed mouse cells. J Virol (1972) 0.93
Effect of helper virus on the number of murine sarcoma virus DNA copies in infected mammalian cells. J Virol (1977) 0.93
Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice. Virology (1976) 0.92
Two levels of restriction by mouse or cat cells of murine sarcoma virus coated by endogenous xenotropic oncornavirus. J Gen Virol (1975) 0.92
Oncoduction. A unifying hypothesis of viral carcinogenesis. Prog Exp Tumor Res (1974) 0.92
Effect of infection with Moloney sarcoma and leukemia viruses on nucleic acid synthesis in mouse cell cultures. J Natl Cancer Inst (1970) 0.92
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120). Vaccine (1989) 0.90
Thymotropic envelope gene recombinants of Moloney leukemia virus have highly conserved envelope structures. Virology (1985) 0.90
Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines. Cancer Res (1982) 0.89
Role of heated adenovirus 2 in viral interference. Proc Soc Exp Biol Med (1965) 0.89
Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71. Virology (1979) 0.89
The inhibition by cytosine arabinoside of the replication of murine leukemia and sarcoma viruses in mouse embryo cultures. Int J Cancer (1969) 0.88
Toward a vaccine against AIDS: rationale and current progress. Mt Sinai J Med (1986) 0.87
Lipoprotein-associated oncornavirus-inactivating factor in the genus Mus: effects on murine leukemia viruses of laboratory and exotic mice. Cancer Res (1987) 0.87
Replication of defective and competent forms of murine sarcoma virus in mouse cell cultures. Virology (1970) 0.87
Properties of mouse leukemia viruses. XIV. Prevention of spontaneous AKR leukemia by treatment with group-specific antibody against the major virus gp71 glycoprotein. Virology (1977) 0.87
XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells. Virology (1982) 0.86
Detection of a recombinant murine leukemia virus-related glycoprotein on virus-negative thymoma cells. Proc Natl Acad Sci U S A (1981) 0.86
Revertants of mouse cells transformed by murine sarcoma virus. II. Flat variants induced by fluordeoxyuridine and colcemid. Virology (1973) 0.85
Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. J Natl Cancer Inst (1981) 0.85
HTLV-III antibody in a breeding chimpanzee not experimentally exposed to the virus. Lancet (1986) 0.83
Expression of the defective "S plus L-" type murine sarcoma virus genome in human amnion and lung cells. J Natl Cancer Inst (1974) 0.82
Ultraviolet inactivation of Moloney leukaemia virus: relative target size required for virus replication and rescue of 'defective' murine sarcoma virus. J Gen Virol (1972) 0.82
Microinjection and expression of an infectious proviral clone and subgenomic envelope construct of a human immunodeficiency virus. AIDS Res Hum Retroviruses (1988) 0.79
Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein. Haematol Blood Transfus (1987) 0.78
Revertants of mouse cells transformed by murine sarcoma virus: flat variants without a rescuable sarcoma virus from a clone of BALB/3T3 transformed by Kirsten MSV. J Gen Virol (1974) 0.78
Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. J Exp Med (1974) 0.78
Presence of a novel recombinant murine leukemia virus-like glycoprotein on the surface of virus-negative C57BL lymphoma cells. Cancer Res (1982) 0.78
Activating and protective capacities of a purified electrophoretic fraction of murine leukemia virus for murine leukemia virus infectivity. Proc Natl Acad Sci U S A (1972) 0.78
Biological, immunological, and molecular properties of revertants of cat cells transformed by murine sarcoma virus. Cancer Res (1981) 0.78
Properties of 3T3 cells transformed by murine sarcoma virus in the absence of replicating murine leukemia helper virus. Bibl Haematol (1973) 0.77
Rapid assessment of relationships among HIV isolates by oligopeptide analyses of external envelope glycoproteins. AIDS Res Hum Retroviruses (1987) 0.77
Isolation of two novel envelope recombinant leukemogenic viruses from Moloney leukemia virus stocks. Int J Cancer (1981) 0.77
Induction of a novel transforming virus (MSV-Z) from sarcoma-positive leukemia-negative 3T3FL mouse cells. Virology (1976) 0.77